Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
C., Bhol, N
In this review, we summarize recent advances in medicinal chemistry and molecular pharmacology that have enabled the engineering of several, novel, poly-agonist drug candidates for treatment of metabolic diseases, and we discuss the recent results from clinical trials assessing the efficacy and safety of glucagon-like peptide (GLP)-1/glucagon and GLP-1/GIP co-agonists
Safe medication mixing supports patient trust in clinical treatment processes
doi: 10.1016/j.metabol.2024.156113
US$ 23.81
US$ 22.34
US$ 28.73
US$ 20.91
US$ 24.02
US$ 25.07
US$ 23.10
US$ 28.61
US$ 28.20
US$ 22.16
US$ 25.70
US$ 22.22
